Respiratory DC Use IFITM3 to Avoid Direct Viral Infection and Safeguard Virus-Specific CD8+ T Cell Priming
Overview
Authors
Affiliations
Respiratory dendritic cells (DC) play a pivotal role in the initiation of adaptive immune responses to influenza virus. To do this, respiratory DCs must ferry viral antigen from the lung to the draining lymph node without becoming infected and perishing en route. We show that respiratory DCs up-regulate the expression of the antiviral molecule, interferon-induced transmembrane protein 3 (IFITM3) in response to influenza virus infection, in a manner dependent on type I interferon signaling and the transcription factors IRF7 and IRF3. Failure of respiratory DCs to up-regulate IFITM3 following influenza virus infection resulted in impaired trafficking to the draining LN and consequently in impaired priming of an influenza-specific CD8+ T cell response. The impaired trafficking of IFITM3-deficient DC correlated with an increased susceptibility of these DC to influenza virus infection. This work shows that the expression of IFITM3 protects respiratory DCs from influenza virus infection, permitting migration from lung to LN and optimal priming of a virus specific T-cell response.
Influenza Virus Host Restriction Factors: The ISGs and Non-ISGs.
Husain M Pathogens. 2024; 13(2).
PMID: 38392865 PMC: 10893265. DOI: 10.3390/pathogens13020127.
Yau E, Yang L, Chen Y, Umstead T, Stanley A, Halstead E Microbes Infect. 2023; 26(3):105280.
PMID: 38135024 PMC: 10948314. DOI: 10.1016/j.micinf.2023.105280.
Interferon-induced transmembrane protein 3 (IFITM3) limits lethality of SARS-CoV-2 in mice.
Kenney A, Zani A, Kawahara J, Eddy A, Wang X, Mahesh K EMBO Rep. 2023; 24(4):e56660.
PMID: 36880581 PMC: 10074051. DOI: 10.15252/embr.202256660.
IFITM protein regulation and functions: Far beyond the fight against viruses.
Friedlova N, Zavadil Kokas F, Hupp T, Vojtesek B, Nekulova M Front Immunol. 2022; 13:1042368.
PMID: 36466909 PMC: 9716219. DOI: 10.3389/fimmu.2022.1042368.
Antigen Presentation in the Lung.
Kawasaki T, Ikegawa M, Kawai T Front Immunol. 2022; 13:860915.
PMID: 35615351 PMC: 9124800. DOI: 10.3389/fimmu.2022.860915.